• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Novavax deliveries arrive in Canada

Mary Wilson

Well-known member
Published Thursday, March 31, 2022 5:40 PM EDT
Last Updated Thursday, March 31, 2022 5:40 PM EDT

Maggie Parkhill

Canada has received its first shipments of the Novavax COVID-19 vaccine, and delivery to the provinces is currently underway, according to the federal government.

In a tweet posted on Thursday, Health Canada and the Public Health Agency of Canada (PHAC) confirmed that the federal government has received 3.2 million doses of Novavax's Nuvaxovid vaccine, with one million doses already distributed to the provinces and territories based on supply and demand. ...

... The Novavax vaccine differs from the Pfizer-BioNTech and Moderna vaccines in that it is a protein-based vaccine and not an mRNA vaccine.

The two-dose Nuvaxovid vaccine produced by the U.S. biotech firm Novavax showed 90 per cent effectiveness in protecting clinical trial participants from symptomatic COVID-19, and 100 per cent effectiveness in preventing severe disease, according to a press release from the company.

Health Canada authorized the use of the Novavax vaccine on Feb. 17 for people 18 years of age and older. ...

https://www.ctvnews.ca/health/coronavirus/novavax-deliveries-arrive-in-canada-1.5843358
 
Back
Top